Information  X 
Enter a valid email address

Science Group PLC (SAG)

  Print      Mail a friend

Tuesday 17 September, 2019

Science Group PLC

Transaction in Own Shares

RNS Number : 5206M
Science Group PLC
17 September 2019
 

 

 

17 September 2019

 

Science Group plc

(the "Company" or "Science Group")

 

Transaction in own shares

 

Science Group plc (AIM:SAG) announces that, on 16 September 2019, it purchased 2,000 of its 1 pence ordinary shares at an average price of 190.0 pence per share. The highest price paid per share was 190 pence and the lowest price paid per share was 190.0 pence. The Company purchased these shares through Panmure Gordon (UK) Limited.

The number of shares purchased represented 0.005% of the voting rights attributable to the total ordinary shares in issue prior to the purchase. The purchased shares will be held in treasury.

The total number of ordinary shares in issue (excluding treasury shares) following this announcement is 41,128,229.  Science Group holds 933,806 shares in treasury.

Schedule of Purchases - Individual Transactions

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation), the schedule below contains detailed information about the purchases made by Panmure Gordon (UK) Limited on behalf of the Company as part of the buyback programme.

 

Number of shares purchased

Transaction price (per share)

Time of transaction

Execution venue

2000

190.0

14:07:27

AIMX

 

- Ends -

 

For further information:

Science Group plc


Sarah Cole, Company Secretary

Tel: +44 (0) 1223 875 200

 

Panmure Gordon (UK) Limited


Nominated Adviser: Dominic Morley/Alina Vaskina

Tel: +44 (0) 20 7886 2500

Corporate Broking: Erik Anderson


 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
POSCKADQOBKDNCD

a d v e r t i s e m e n t